Phenomex Inc (CELL) Inventory Turnover Ratio, from second quarter 2023 to second quarter 2022, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Phenomex Inc   (NASDAQ: CELL)
 

Phenomex Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Phenomex Inc 's inventory turnover ratio, the ratio that measures Phenomex Inc 's ability to manage its supply chain, sequentially decreased to 0.83 in the second quarter 2023, which does not come as a surprise, as the Phenomex Inc continue to experience headwinds, which also impact its supply chain. Phenomex Inc 's average inventory processing period in the Jun 30 2023 quarter, has increased to 440 days, from 372 days, in the Mar 31 2023 quarter.

Within Healthcare sector 375 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1433 in the first quarter 2023, to 1484.

CELL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Phenomex Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CELL Inventory Turnover Ratio (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Inventory Growth 164.65 % 190.71 % 29.66 % 18.89 % 24.59 %
Y / Y Cost of Sales Growth 28.53 % -20.24 % -19.22 % -28.48 % -4.57 %
Inventory Turnover Ratio (TTM) 0.83 0.98 1.51 1.7 1.95
CELL's Total Ranking # 1484 # 1433 # 1827 # 1905 # 1899
Average inventory processing period 438 372 242 214 188
Seq. Inventory Growth -8.97 % 141.45 % 20.09 % 0.27 % -0.01 %
Seq. Cost of Sales Growth 57.23 % -12.85 % -8.39 % 2.39 % -2.43 %




Inventory Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 27
Healthcare Sector # 376
Overall Market # 1484

Inventory Turnover Ratio Statistics
High Average Low
2.39 1.78 0.83
(Sep 30 2021)   (Jun 30 2023)



CELL Company Profile >> Back to CELL Efficiency Comparisons >> Compare CELL Inventory Turnover Ratio to its Competitors

Financial Statements
Phenomex Inc 's Inventories $ 41 Millions Visit CELL's Balance sheet
Phenomex Inc 's Cost of Revenues TTM $ 25 Millions Visit CELL's Income Statement
What are CELL's Sales? Visit CELL's Sales by Segment

Other Inventory Turnover Ratios
Phenomex Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CELL's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CELL's Competitors
Inventory Turnover Ratio for CELL's Suppliers
Inventory Turnover Ratio for CELL's Customers

You may also want to know
CELL's Sales Growth Rates CELL's Pe Price to earnings ratio CELL's Receivables Turnover Ratio CELL's Stock Quote
CELL's Net Income Growth Rates CELL's Ps Price to Sales ratio CELL's Sales per Employee CELL's Asset Turnover Ratio
CELL's Net Margin CELL's Pb Price to Book ratio CELL's Financial Strength Ratios CELL's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2023 Inventories at quarter ending Jun 30 2023
Alnylam Pharmaceuticals Inc   1.67 $ 199.447  Millions$ 119  Millions
Y mabs Therapeutics inc   1.66 $ 11.228  Millions$ 7  Millions
Conmed Corporation  1.63 $ 529.587  Millions$ 325  Millions
Yunhong Green Cti Ltd   1.63 $ 13.461  Millions$ 8  Millions
Emergent Biosolutions Inc   1.61 $ 651.700  Millions$ 405  Millions
Accelerate Diagnostics Inc   1.59 $ 8.313  Millions$ 5  Millions
Neurometrix Inc   1.58 $ 2.374  Millions$ 2  Millions
Bruker Corporation  1.58 $ 1,312.700  Millions$ 831  Millions
Halozyme Therapeutics Inc   1.58 $ 174.679  Millions$ 111  Millions
Ligand Pharmaceuticals Incorporated  1.57 $ 30.114  Millions$ 19  Millions
Keenova Therapeutics Plc  1.57 $ 1,480.000  Millions$ 944  Millions
Anika Therapeutics Inc   1.57 $ 63.057  Millions$ 40  Millions
Neuropace Inc   1.56 $ 15.278  Millions$ 10  Millions
Acorda Therapeutics Inc   1.55 $ 21.864  Millions$ 14  Millions
Artivion Inc   1.55 $ 117.106  Millions$ 76  Millions
Inmed Pharmaceuticals Inc  1.53 $ 2.424  Millions$ 2  Millions
Xtant Medical Holdings Inc   1.53 $ 27.937  Millions$ 18  Millions
Innovative Eyewear Inc   1.51 $ 0.727  Millions$ 0  Millions
Alpha Pro Tech Ltd   1.51 $ 36.136  Millions$ 24  Millions
Insulet Corporation  1.51 $ 554.100  Millions$ 368  Millions
Stablecoin Development Corporation  1.50 $ 5.627  Millions$ 4  Millions
Procept Biorobotics Corporation  1.50 $ 49.807  Millions$ 33  Millions
Inari Medical Inc   1.50 $ 51.777  Millions$ 34  Millions
Eli Lilly And Company  1.50 $ 6,561.300  Millions$ 4,371  Millions
Seer Inc   1.50 $ 7.305  Millions$ 5  Millions
Vapotherm Inc   1.49 $ 45.918  Millions$ 31  Millions
Eagle Pharmaceuticals inc   1.48 $ 73.269  Millions$ 50  Millions
Atrion Corporation  1.47 $ 103.155  Millions$ 70  Millions
Alphatec Holdings Inc   1.46 $ 158.101  Millions$ 108  Millions
Establishment Labs Holdings Inc   1.46 $ 62.298  Millions$ 43  Millions

Date modified: 2026-08-29T17:42:08+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.